Problem fit
Alignment with the clinical, operational, commercial, or strategic need and the intended user and care setting.
Startup and partner scouting
Digital Health Startup & Partner Scouting
Move from a broad innovation landscape to a defensible shortlist of ventures and partners matched to a real strategic need.
The decision context
The scouting problem is selection, not discovery
Healthcare teams can find thousands of companies through databases, conferences, and inbound channels. The harder task is deciding which ventures fit the problem, meet the evidence threshold, can work with an enterprise, and deserve scarce diligence and implementation capacity.
Galen Growth combines structured search, market intelligence, company evidence, and expert review to produce shortlists that are transparent, comparable, and ready for engagement.
What Galen Growth evaluates
Evidence organised around the decision
Company maturity
Commercial traction, organisation, funding, customers, partnerships, and ability to support enterprise delivery.
Evidence and readiness
Clinical validation, regulatory status, security, integration, implementation, and geographic readiness.
Partnership potential
Strategic fit, differentiation, collaboration model, dependencies, and a credible route from introduction to scale.
HealthTech Alpha evidence
Scouting grounded in structured company records
HealthTech Alpha gives the search a defined taxonomy and a connected evidence base spanning ventures, products, funding, partnerships, clinical activity, regulation, team, and market presence. Expert review then tests relevance and removes false positives that keyword searches routinely introduce.
- Ontology-led venture discovery
- Custom inclusion and exclusion criteria
- Evidence-based scoring and shortlisting
- Partner profiles and engagement priorities
Methodology
From question to defensible action
- Specify the need
Define the problem, user, geography, maturity, evidence, integration, and commercial requirements before searching.
- Scan and screen
Build the longlist from structured data and screen every candidate against documented criteria.
- Evaluate deeply
Compare the strongest candidates across fit, traction, evidence, readiness, differentiation, and risk.
- Prepare engagement
Deliver a prioritised shortlist, company profiles, rationale, open questions, and recommended next steps.
Related case studies
How Galen Growth has supported these decisions
Building a Startup Bridge in APAC for HPV, Cervical Cancer and Immuno-Oncology
Enabled the client to open structured partnership conversations with high-potential APAC startups and investors.
Selecting Personal Health Ventures for Two Priority Therapeutic Areas
Enabled BD and franchise teams to enter partnership conversations with a defensible top-10.
Decoding the Pan-Omics Venture Landscape Across Europe and Asia
Enabled the biotech to focus partnership and licensing engagement on a defensible prioritised set.
Shortlisting GDPR-Ready Telemonitoring Ventures for Heart Failure
Enabled the franchise to move from scouting to partnership selection with a decision-ready top 3-5.
Related research
Evidence behind the market
Sectors
Designed for healthcare decisions
- Biopharma
- Medical device
- Health systems
- Insurance
- Investors
- Innovation ecosystems
FAQ
Common questions
What is digital health startup scouting?
It is the structured process of finding, screening, comparing, and prioritising digital health ventures against a defined strategic, clinical, commercial, or investment need.
How do you avoid irrelevant startup matches?
The search begins with explicit inclusion and exclusion criteria, uses an ontology rather than keywords alone, and applies expert review before companies enter the shortlist.
Can Galen Growth arrange introductions?
Scouting can include company profiling and engagement preparation, with introductions or follow-on evaluation scoped according to the programme.
Related capabilities
Explore other decision areas
Your decision context
Bring us the question that needs a defensible answer.
We will help define the evidence, scope, and practical route from analysis to action.